Influence of Derivatisation of the Hydroxy Groups in 1,1-Bis-(4-hydroxyphenyl)-2-phenylbut-1-ene on Estradiol Receptor Affinity and Mammary Tumor Inhibiting Properties-Reference-Cited by-同舟云学术

Influence of Derivatisation of the Hydroxy Groups in 1,1-Bis-(4-hydroxyphenyl)-2-phenylbut-1-ene on Estradiol Receptor Affinity and Mammary Tumor Inhibiting Properties

Published:1987 Issue:7 Volume:320 Page:635-641
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:de
Short-container-title:Arch. Pharm. Pharm. Med. Chem.

Author:

Schuderer Michael L.,Schneider Martin R.

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Reference17 articles.

1. in Antihormones, p. 235, Elsevier, Amsterdam, 1979.

2. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite

3. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model

4. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigations on the influence of terminal groups at the C2-propyl side chain of 1,1-bis(4-hydroxyphenyl)-2-phenylpent-1-ene and 1,1,2-tris(4-hydroxyphenyl)pent-1-ene on the estrogen receptor binding and the estrogenic/anti-estrogenic properties;The Journal of Steroid Biochemistry and Molecular Biology;2003-07

2. Investigations on Estrogen Receptor Binding. The Estrogenic, Antiestrogenic, and Cytotoxic Properties of C2-Alkyl-Substituted 1,1-Bis(4-hydroxyphenyl)-2-phenylethenes;Journal of Medicinal Chemistry;2002-10-23

3. Crystal structure and hormonal activity of 1,1-bis(4-hydroxyphenyl)-2-phenylethene;Monatshefte für Chemie - Chemical Monthly;1993-11

4. Cytotoxic Ester Derivatives of the Mammary Tumor Inhibiting Antiestrogen 2,3-Bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane;Archiv der Pharmazie;1990

5. 1-[4-(N,N-Bis-β-chloroethylcarbamoyloxy)-phenyl]-1,2-bis-(hydroxyphenyl)-but-1-enes: Drugs Specifically Targeted against Estrogen Receptor Positive Mammary Tumors;Archiv der Pharmazie;1990